Abeona Therapeutics Inc.

ABEO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$5$109-$12-$9
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$3$3$2
Change in WC-$17$16-$3-$4
Other Non-Cash$0-$147-$6-$6
Operating Cash Flow-$21-$19-$18-$17
Investing Activities
PP&E Inv.-$3-$3-$1-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$100-$20-$49-$10
Inv. Sales/Matur.$38$26$54$30
Other Inv. Act.$0$152$0$0
Investing Cash Flow-$65$156$4$19
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$5$11$7$6
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0-$0-$0
Financing Cash Flow$5$10$7$5
Forex Effect-$0$0$0$0
Net Chg. in Cash-$81$148-$7$8
Supplemental Information
Beg. Cash$164$16$24$16
End Cash$83$164$16$24
Free Cash Flow-$24-$22-$20-$17
Abeona Therapeutics Inc. (ABEO) Financial Statements & Key Stats | AlphaPilot